57
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer

      research-article
      , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ICGC Breast Cancer Group
      , ICGC Chronic Myeloid Disorders Group
      , ICGC Prostate Cancer Group
      , , , , , , , , , , , , , , , , , *
      eLife
      eLife Sciences Publications, Ltd
      mitochondrial DNA, somatic mutation, mutational signature, cancer genome, evolution, sequencing, human
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Recent sequencing studies have extensively explored the somatic alterations present in the nuclear genomes of cancers. Although mitochondria control energy metabolism and apoptosis, the origins and impact of cancer-associated mutations in mtDNA are unclear. In this study, we analyzed somatic alterations in mtDNA from 1675 tumors. We identified 1907 somatic substitutions, which exhibited dramatic replicative strand bias, predominantly C > T and A > G on the mitochondrial heavy strand. This strand-asymmetric signature differs from those found in nuclear cancer genomes but matches the inferred germline process shaping primate mtDNA sequence content. A number of mtDNA mutations showed considerable heterogeneity across tumor types. Missense mutations were selectively neutral and often gradually drifted towards homoplasmy over time. In contrast, mutations resulting in protein truncation undergo negative selection and were almost exclusively heteroplasmic. Our findings indicate that the endogenous mutational mechanism has far greater impact than any other external mutagens in mitochondria and is fundamentally linked to mtDNA replication.

          DOI: http://dx.doi.org/10.7554/eLife.02935.001

          eLife digest

          The DNA in a cell's nucleus must be copied faithfully, and divided equally, when a cell divides to produce two new cells. Mistakes—or mutations—are sometimes made during the copying process, and mutations can also be introduced by exposing DNA to damaging agents known as mutagens, such as UV light or cigarette smoke. These mutations are then maintained in all of the descendants of the cell. Most of these mutations have no impact on the cell's characteristics (‘passenger mutations’). However, ‘driver mutations’ that allow cells to divide uncontrollably and spread to other body sites can lead to cancer.

          Mitochondria are cellular compartments that are responsible for generating the energy a cell needs to survive and are also responsible for initiating programmed cell death. Mitochondria contain their own DNA—entirely separate from that in the nucleus of the cell—that encodes the proteins most essential for energy production. Mitochondrial DNA molecules are frequently exposed to damaging molecules called reactive oxygen species that are produced by the mitochondria. Therefore, these reactive oxygen species have been thought to be one of the most important causes of mitochondrial DNA mutations. In addition, because cancer cells produce energy differently to normal cells, mutations in the mitochondrial DNA that change the ability of the mitochondria to produce energy have been conventionally thought to help normal cells to become cancerous. However, conclusive evidence for a link between cancer and mitochondrial DNA mutations is lacking.

          Ju et al. examined the mitochondrial DNA sequences taken from 1675 cancer biopsies from over thirty different types of cancer and compared these to normal tissue from the same patients. This revealed 1907 mutations in the mitochondrial DNA taken from the cancer cells. The pattern of the mutations suggests that the majority of the mutations are not introduced from reactive oxygen species, but from the errors the mitochondria themselves make in the process of duplicating their DNA when a cell divides. Unexpectedly, known mutagens, such as cigarette smoke or UV light, had a negligible effect on mitochondrial DNA mutations.

          Contrary to conventional wisdom, Ju et al. found no evidence that the mitochondrial DNA mutations help cancer to develop or spread. Instead, like passenger mutations found in the DNA in the cell nucleus, most mitochondrial genome mutations have no discernible effect. However, Ju et al. revealed that DNA mutations that damage normal mitochondrial activity are less likely to be maintained in cancer cells. Presumably, mitochondria containing these proteins produce less energy, and so a cell containing too many of these mutations will find it harder to survive. This shows that having enough correctly functioning mitochondria is essential for even cancer cells to thrive.

          DOI: http://dx.doi.org/10.7554/eLife.02935.002

          Related collections

          Most cited references62

          • Record: found
          • Abstract: found
          • Article: found

          Hallmarks of Cancer: The Next Generation

          The hallmarks of cancer comprise six biological capabilities acquired during the multistep development of human tumors. The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease. They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions. Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metabolism and evading immune destruction. In addition to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment." Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer. Copyright © 2011 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Fast and accurate short read alignment with Burrows–Wheeler transform

            Motivation: The enormous amount of short reads generated by the new DNA sequencing technologies call for the development of fast and accurate read alignment programs. A first generation of hash table-based methods has been developed, including MAQ, which is accurate, feature rich and fast enough to align short reads from a single individual. However, MAQ does not support gapped alignment for single-end reads, which makes it unsuitable for alignment of longer reads where indels may occur frequently. The speed of MAQ is also a concern when the alignment is scaled up to the resequencing of hundreds of individuals. Results: We implemented Burrows-Wheeler Alignment tool (BWA), a new read alignment package that is based on backward search with Burrows–Wheeler Transform (BWT), to efficiently align short sequencing reads against a large reference sequence such as the human genome, allowing mismatches and gaps. BWA supports both base space reads, e.g. from Illumina sequencing machines, and color space reads from AB SOLiD machines. Evaluations on both simulated and real data suggest that BWA is ∼10–20× faster than MAQ, while achieving similar accuracy. In addition, BWA outputs alignment in the new standard SAM (Sequence Alignment/Map) format. Variant calling and other downstream analyses after the alignment can be achieved with the open source SAMtools software package. Availability: http://maq.sourceforge.net Contact: rd@sanger.ac.uk
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Signatures of mutational processes in human cancer

              All cancers are caused by somatic mutations. However, understanding of the biological processes generating these mutations is limited. The catalogue of somatic mutations from a cancer genome bears the signatures of the mutational processes that have been operative. Here, we analysed 4,938,362 mutations from 7,042 cancers and extracted more than 20 distinct mutational signatures. Some are present in many cancer types, notably a signature attributed to the APOBEC family of cytidine deaminases, whereas others are confined to a single class. Certain signatures are associated with age of the patient at cancer diagnosis, known mutagenic exposures or defects in DNA maintenance, but many are of cryptic origin. In addition to these genome-wide mutational signatures, hypermutation localized to small genomic regions, kataegis, is found in many cancer types. The results reveal the diversity of mutational processes underlying the development of cancer with potential implications for understanding of cancer etiology, prevention and therapy.
                Bookmark

                Author and article information

                Contributors
                Role: Reviewing editor
                Journal
                eLife
                eLife
                eLife
                eLife
                eLife Sciences Publications, Ltd
                2050-084X
                2050-084X
                01 October 2014
                2014
                : 3
                : e02935
                Affiliations
                deptCambridge Breast Unit , Addenbrooke’s Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre , Cambridge CB2 2QQ, UK
                deptDepartment of Pathology , Academic Medical Center, Meibergdreef 9 , 1105 AZ Amsterdam, The Netherlands
                deptDepartment of Cancer Biology , Dana-Farber Cancer Institute , 450 Brookline Ave., Boston, Massachusetts 02215, USA
                deptDepartment of Pathology , Brigham and Women's Hospital, Harvard Medical School , 75 Francis St., Boston, Massachusetts 02115, USA
                East of Scotland Breast Service, Ninewells Hospital , Dundee, United Kingdom
                deptDepartment of Research Oncology , Guy’s Hospital, King’s Health Partners AHSC, King’s College London School of Medicine , London SE1 9RT, UK
                Institut Bergonié, 229 cours de l’Argone, 33076 , Bordeaux, France
                Institut Curie, Department of Tumor Biology, 26 rue d’Ulm , 75248 Paris cédex 05, France
                Institut Curie, INSERM Unit 830, 26 rue d’Ulm , 75248 Paris cédex 05, France
                deptDepartment of Pathology , Jules Bordet Institute , Brussels 1000, Belgium
                deptDepartment of Pathology , Skåne University Hospital, Lund University , SE-221 85 Lund, Sweden
                deptDepartment of Pathology , Oslo University Hospital Ulleval and University of Oslo, Faculty of Medicine and Institute of Clinical Medicine , Oslo, Norway
                deptDepartment of Pathology , Oslo University Hospital Ulleval and University of Oslo, Faculty of Medicine and Institute of Clinical Medicine , Oslo, Norway
                deptDepartment of Gynecology & Obstetrics, Department of Clinical Sciences , Lund University, Skåne University Hospital Lund , SE-221 85 Lund, Sweden
                Translational Cancer Research Unit, GZA Hospitals St.-Augustinus , Antwerp, Belgium
                deptDepartment of Pathology , Erasmus Medical Center , Rotterdam, the Netherlands
                deptBreast Cancer Translational Research Laboratory , Institut Jules Bordet, Université Libre de Bruxelles , Brussels, Belgium
                deptDepartment of Pathology , Brigham and Women's Hospital, Harvard Medical School , 75 Francis St., Boston, Massachusetts 02115, USA
                The University of Queensland, School of Medicine, Herston , Brisbane, QLD 4006, Australia
                Pathology Queensland: The Royal Brisbane & Women’s Hospital , Brisbane, QLD 4029, Australia
                The University of Queensland, UQ Centre for Clinical Research, Herston , Brisbane, QLD 4029, Australia
                deptDepartment of Pathology , Memorial Sloan-Kettering Cancer Center , New York, NY, USA
                Centre Georges-François Leclerc , 1 rue du Professeur Marion, 21079, Dijon, France
                0nstitut Paoli Calmettes , deptbiopathology department , 232 Bd Ste Marguerite, 13009, Marseille, France
                Centre Léon Bérard , Lyon, France; Université Claude Bernard Lyon1 - Université de Lyon , Lyon, France
                deptCambridge Breast Unit, Addenbrooke’s Hospital , Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre , Cambridge CB2 2QQ, UK
                deptDepartment of Oncology , University of Cambridge and Cancer Research UK Cambridge Research Institute, Li Ka Shin Centre , Cambridge CB2 0RE
                deptDepartment of Oncology , University of Cambridge and Cancer Research UK Cambridge Research Institute, Li Ka Shin Centre , Cambridge CB2 0RE
                deptDepartment of Cancer Biology , Dana-Farber Cancer Institute , 450 Brookline Ave., Boston, Massachusetts 02215, USA
                Dundee Cancer Centre, Ninewells Hospital , Dundee, UK
                Dundee Cancer Centre, Ninewells Hospital , Dundee, UK
                Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam, The Netherlands
                Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam, The Netherlands
                Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam, The Netherlands
                Radboud University , deptDepartment of Molecular Biology, Faculty of Science, Nijmegen Centre for Molecular Life Sciences , 6500 HB Nijmegen, The Netherlands
                Radboud University , deptDepartment of Molecular Biology, Faculty of Science, Nijmegen Centre for Molecular Life Sciences , 6500 HB Nijmegen, The Netherlands
                deptDepartment of Radiation Oncology , Radboud University Medical Centre , Nijmegen, The Netherlands
                deptDepartment of Laboratory Medicine , Radboud University Medical Centre , Nijmegen, The Netherlands
                deptBreast Cancer Translational Research Laboratory , Institut Jules Bordet, Université Libre de Bruxelles , Brussels, Belgium
                deptBreast Cancer Translational Research Laboratory , Institut Jules Bordet, Université Libre de Bruxelles , Brussels, Belgium
                Universite Lyon1, INCa-Synergie, Centre Leon Berard , 28 rue Laennec Lyon Cedex 08France
                deptDepartment Experimental Therapy , The Netherlands Cancer Institute , Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
                deptDepartment of Genetics , Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital , O310 Oslo, Norway
                deptDepartment of Molecular Oncology , BC Cancer Agency , 675 W10th Avenue, Vancouver V5Z 1L3
                The University of Queensland, UQ Centre for Clinical Research , Herston, Brisbane, QLD 4029, Australia
                The Netherlands Cancer Institute , deptDivision of Molecular Carcinogenesis , Amsterdam, The Netherlands
                deptDepartment of Surgery , University of California, San Francisco , San Francisco, California, United States of America
                deptCancer Research Laboratory, Faculty of Medicine , University of Iceland , Reykjavik, Iceland
                deptCancer Research Laboratory, Faculty of Medicine , University of Iceland , Reykjavik, Iceland
                deptDepartment of Pathology , University Hospital , Reykjavik, Iceland
                deptIcelandic Cancer Registry , Icelandic Cancer Society , Skogarhlid 8, P.O.Box 5420, 125, Reykjavik, Iceland
                deptDepartment of Genetics , Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital , O310 Oslo, Norway
                deptInstitute for Clinical Medicine, Faculty of Medicine , University of Oslo
                deptNational Genotyping Center , Institute of Biomedical Sciences , Academia Sinica, 128 Academia Road, Sec 2, Nankang, Taipei 115, Taiwan, ROC
                deptNCCS-VARI Translational Research Laboratory , National Cancer Centre Singapore , 11 Hospital Drive, 169610, Singapore
                deptDepartment of General Surgery , Singapore General Hospital , Singapore
                deptDepartment of Pathology , Academic Medical Center , Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
                Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
                Division of Medial Sciences, University of Dundee, Dundee, UK
                deptNuffield Department of Clinical Laboratory Sciences , University of Oxford , UK
                deptNuffield Department of Clinical Laboratory Sciences , University of Oxford , UK
                deptDivision of Medial Sciences , University of Dundee , Dundee, UK
                deptWeatherall Institute of Molecular Medicine , University of Oxford , UK
                deptDepartment of Haematology , Great Western Hospital , Swindon, UK
                deptDepartment of Haematology , University of Milan Bicocca , Milan, Italy
                deptWeatherall Institute of Molecular Medicine , University of Oxford , UK
                deptDepartment of Haematology , Karolinska Institute , Stockholm, Sweden
                St James Institute of Oncology, St James Hospital , Leeds, UK
                deptSchool of Medicine , University of Southampton , Southampton, UK
                deptDepartment of Haematology , University of Cambridge , Cambridge, UK
                deptFondazione IRCCS Policlinico San Matteo , University of Pavia , Pavia, Italy
                deptDivision of Genetics and Epidemiology , The Institute Of Cancer Research, Sutton , UK
                deptDepartment of Biological Sciences and School of Medicine , University of East Anglia , Norwich, UK
                Senior Principal Investigators of the Cancer Research UK funded ICGC Prostate Cancer Project
                deptDivision of Genetics and Epidemiology , The Institute Of Cancer Research, Sutton , UK
                Royal Marsden NHS Foundation Trust , London and Sutton, UK
                Senior Principal Investigators of the Cancer Research UK funded ICGC Prostate Cancer Project
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptHuman Genome Laboratory, Department of Human Genetics , VIB and KU Leuven , Leuven, Belgium
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptStatistics and Computational Biology Laboratory , Cancer Research UK Cambridge Research Institute , Cambridge, UK
                deptDivision of Genetics and Epidemiology , The Institute Of Cancer Research, Sutton , UK
                deptDivision of Genetics and Epidemiology , The Institute Of Cancer Research, Sutton , UK
                deptUrological Research Laboratory , Cancer Research UK Cambridge Research Institute , Cambridge, UK
                deptDivision of Genetics and Epidemiology , The Institute Of Cancer Research, Sutton , UK
                Royal Marsden NHS Foundation Trust , London and Sutton, UK
                deptDivision of Genetics and Epidemiology , The Institute Of Cancer Research, Sutton , UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptUrological Research Laboratory , Cancer Research UK Cambridge Research Institute , Cambridge, UK
                deptDepartment of Histopathology , St Georges Hospital , London, UK
                Royal Marsden NHS Foundation Trust , London and Sutton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptDivision of Genetics and Epidemiology , The Institute Of Cancer Research, Sutton , UK
                deptDepartment of Biological Sciences and School of Medicine , University of East Anglia , Norwich, UK
                deptDepartment of Biological Sciences and School of Medicine , University of East Anglia , Norwich, UK
                deptInstitute of Food Research , Norwich Research Park , Norwich, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptSchool of Computing Sciences , University of East Anglia , Norwich, UK
                deptDepartment of Molecular Oncology , Barts Cancer Centre, Barts and the London School of Medicine and Dentistry , London, UK
                Royal Marsden NHS Foundation Trust , London and Sutton, UK
                Royal Marsden NHS Foundation Trust , London and Sutton, UK
                Royal Marsden NHS Foundation Trust , London and Sutton, UK
                Royal Marsden NHS Foundation Trust , London and Sutton, UK
                Royal Marsden NHS Foundation Trust , London and Sutton, UK
                Royal Marsden NHS Foundation Trust , London and Sutton, UK
                Royal Marsden NHS Foundation Trust , London and Sutton, UK
                Royal Marsden NHS Foundation Trust , London and Sutton, UK
                Royal Marsden NHS Foundation Trust , London and Sutton, UK
                Royal Marsden NHS Foundation Trust , London and Sutton, UK
                deptUrological Research Laboratory , Cancer Research UK Cambridge Research Institute , Cambridge, UK
                deptUrological Research Laboratory , Cancer Research UK Cambridge Research Institute , Cambridge, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                Senior Principal Investigators of the Cancer Research UK funded ICGC Prostate Cancer Project
                deptCentre for Cancer Genetic Epidemiology, Department of Oncology , University of Cambridge , Cambridge, UK
                Senior Principal Investigators of the Cancer Research UK funded ICGC Prostate Cancer Project
                deptDepartment of Histopathology , Cambridge University Hospitals NHS Foundation Trust , Cambridge, UK
                deptBostwick Laboratories , London, UK
                Senior Principal Investigators of the Cancer Research UK funded ICGC Prostate Cancer Project
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                Senior Principal Investigators of the Cancer Research UK funded ICGC Prostate Cancer Project
                deptUrological Research Laboratory , Cancer Research UK Cambridge Research Institute , Cambridge, UK
                deptCancer Genome Project, Wellcome Trust Sanger Institute , Hinxton, UK
                Senior Principal Investigators of the Cancer Research UK funded ICGC Prostate Cancer Project
                deptDivision of Genetics and Epidemiology , The Institute Of Cancer Research, Sutton , UK
                deptDepartment of Biological Sciences and School of Medicine , University of East Anglia , Norwich, UK
                deptUrological Research Laboratory , Cancer Research UK Cambridge Research Institute , Cambridge, UK
                deptDepartment of Surgical Oncology , University of Cambridge, Addenbrooke's Hospital , Cambridge, UK
                Senior Principal Investigators of the Cancer Research UK funded ICGC Prostate Cancer Project
                [1]deptCancer Genome Project , Wellcome Trust Sanger Institute , Hinxton, United Kingdom
                [2]Cambridge University Hospitals NHS Foundation Trust , Cambridge, United Kingdom
                [3]deptDepartment of Haematology , University of Cambridge , Cambridge, United Kingdom
                [4]deptLowy Cancer Research Centre , University of New South Wales , Sydney, Australia
                [5]deptLaboratory of Cancer Epigenome , National Cancer Centre , Singapore, Singapore
                [6]Duke-NUS Graduate Medical School , Singapore, Singapore
                [7]deptDepartment of Hematologic Oncology , Dana-Farber Cancer Institute , Boston, United States
                [8]Institute of Cancer Research, Sutton , London, United Kingdom
                [9]deptWeatherall Institute for Molecular Medicine , University of Oxford , Oxford, United Kingdom
                [10]deptDepartment of Pathology , MD Anderson Cancer Center , Houston, United States
                [11]deptChildren's Brain Tumour Research Centre , University of Nottingham , Nottingham, United Kingdom
                [12]deptNational Institute of Environmental Health Sciences , National Institute of Health , Triangle, North Carolina, United States
                [13]deptDepartment of Internal Medicine , University of North Carolina , Chapel Hill, United States
                [14]deptHospital for Sick Children , University of Toronto , Toronto, Canada
                [15]deptCancer Research UK Cambridge Institute , University of Cambridge , Cambridge, United Kingdom
                [16]deptDepartment of Molecular and Clinical Cancer Medicine , University of Liverpool , London, United Kingdom
                [17]HCA Pathology Laboratories , London, United Kingdom
                [18]deptSchool of Biological Sciences , University of East Anglia , Norwich, United Kingdom
                [19]deptInstitute of Biosciences and Medical Technology - BioMediTech and Fimlab Laboratories , University of Tampere and Tampere University Hospital , Tampere, Finland
                [20]deptDepartment of Oncology , Johns Hopkins University , Baltimore, United States
                [21]deptDepartment of Histopathology , Royal National Orthopaedic Hospital , Middlesex, United Kingdom
                [22]deptUniversity College London Cancer Institute , University College London , London, United Kingdom
                [23]deptDepartment of Genomic Medicine , The University of Texas, MD Anderson Cancer Center, Houston , Texas, United States
                [24]deptWellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine , Newcastle University , Newcastle-upon-tyne, United Kingdom
                Broad Institute , United States
                Broad Institute , United States
                Author notes
                [* ]For correspondence: pc8@ 123456sanger.ac.uk
                Article
                02935
                10.7554/eLife.02935
                4371858
                25271376
                c6df38bb-24e8-45b5-af89-b7d34e20e312

                This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication .

                History
                : 28 March 2014
                : 26 September 2014
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100004440, Wellcome Trust;
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100004440, Wellcome Trust;
                Award ID: Health Innovation Challenge Fund (HICF)
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100000402, Kay Kendall Leukaemia Fund;
                Award Recipient :
                Funded by: Chordoma Foundation;
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100006386, Adenoid Cystic Carcinoma Research Foundation;
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100004410, European Molecular Biology Organization;
                Award ID: ALTF 1203_2012
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100000272, National Institute for Health Research;
                Award ID: Biomedical Research Center at University College London Hospitals
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100000651, Leukaemia and Lymphoma Research;
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100000289, Cancer Research UK;
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100005189, Leukemia and Lymphoma Society;
                Award Recipient :
                Funded by: European Union;
                Award ID: Breast Cancer Somatic Genetics Study (BASIS)
                Award Recipient :
                Funded by: National Cancer Research Institute;
                Award ID: PROMPT: G0500966/75466
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100000066, National Institute of Environmental Health Sciences;
                Award ID: Intramural Research Program of the NIH
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100000272, National Institute for Health Research;
                Award ID: Cambridge Biomedical Research Center
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100004410, European Molecular Biology Organization;
                Award ID: ALTF 1287-2012
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100000276, Department of Health;
                Award ID: Health Innovation Challenge Fund (HICF)
                Award Recipient :
                The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
                Categories
                Research Article
                Genomics and Evolutionary Biology
                Custom metadata
                2
                Identifying 1,907 mitochondrial somatic mutations from 1,675 tumor tissues provides new insights into the causes and effects of the mitochondrial genome mutations found in human cancers.

                Life sciences
                mitochondrial dna,somatic mutation,mutational signature,cancer genome,evolution,sequencing,human

                Comments

                Comment on this article